Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525 
 
Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525 
  
 
Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530 
     free
  
Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531 
     free
      free 
   English Wikipedia
  Nephropedia Template TP (
  Twit Text
 
  DeepDyve Pubget Overpricing |    
 
  lüll The dynorphin/kappa opioid system as a modulator of stress-induced and  pro-addictive behaviors Bruchas MR; Land BB; Chavkin CBrain Res  2010[Feb]; 1314 (ä): 44-55Stress is a complex experience that carries both aversive and motivating  properties. Chronic stress causes an increase in the risk of depression, is well  known to increase relapse of drug seeking behavior, and can adversely impact  health. Several brain systems have been demonstrated to be critical in mediating  the negative affect associated with stress, and recent evidence directly links  the actions of the endogenous opioid neuropeptide dynorphin in modulating mood  and increasing the rewarding effects of abused drugs. These results suggest that  activation of the dynorphin/kappa opioid receptor (KOR) system is likely to play  a major role in the pro-addictive effects of stress. This review explores the  relationship between dynorphin and corticotropin-releasing factor (CRF) in the  induction of dysphoria, the potentiation of drug seeking, and stress-induced  reinstatement. We also provide an overview of the signal transduction events  responsible for CRF and dynorphin/KOR-dependent behaviors. Understanding the  recent work linking activation of CRF and dynorphin/KOR systems and their  specific roles in brain stress systems and behavioral models of addiction  provides novel insight to neuropeptide systems that regulate affective state.|Animals[MESH]|Brain/metabolism/*physiopathology[MESH]|Comorbidity[MESH]|Corticotropin-Releasing Hormone/physiology[MESH]|Dynorphins/*physiology[MESH]|Humans[MESH]|Mood Disorders/chemically induced/metabolism/physiopathology[MESH]|Receptors, Corticotropin-Releasing Hormone/physiology[MESH]|Receptors, Opioid, kappa/*physiology[MESH]|Recurrence[MESH]|Stress, Psychological/metabolism/*physiopathology[MESH]|Substance-Related Disorders/metabolism/*physiopathology[MESH] |